Farabursen (sodium), CAS [[2921918-19-4]]

Produktübersicht

• Artikelname: Farabursen (sodium), CAS [[2921918-19-4]]
• Artikelnummer: MCE-HY-150364A
• Hersteller Artikelnummer: HY-150364A
• Alternativnummer: MCE-HY-150364A-5MG, MCE-HY-150364A-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: RGLS8429 (sodium), RG1015 (sodium)

Produktbeschreibung

Farabursen sodium (RGLS8429 sodium, RG1015 sodium) is a miR-17 inhibitor. Farabursen sodium inhibits the function of the miR-17 family, relieves the inhibitory effect on miR-17 target genes including PKD1 and PKD2, and increases the level of PC1/2. Farabursen sodium slows the growth of renal cysts, reduces the ratio of kidney weight to body weight, and decreases the cyst index and proliferation index. Farabursen sodium is applicable to research related to autosomal dominant polycystic kidney disease[1][2].

Produkteigenschaften

• Molekulargewicht: 3066.4 (free acid)
• Reinheit: 93.56
• CAS Nummer: [2921918-19-4]
• Formel: C95H107F3N32Na8O50P8S8
• Target-Kategorie: MicroRNA

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Oligonucleotides